EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C15H10Cl2N2O2 |
| Net Charge | 0 |
| Average Mass | 321.163 |
| Monoisotopic Mass | 320.01193 |
| SMILES | O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O |
| InChI | InChI=1S/C15H10Cl2N2O2/c16-8-5-6-12-10(7-8)13(19-15(21)14(20)18-12)9-3-1-2-4-11(9)17/h1-7,15,21H,(H,18,20) |
| InChIKey | DIWRORZWFLOCLC-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| Lorazepam (CHEBI:6539) is a benzodiazepine (CHEBI:22720) |
| Synonyms | Source |
|---|---|
| Lorazepam | KEGG COMPOUND |
| Wy-4036 | DrugCentral |
| ativan | DrugCentral |
| Wy 4036 | DrugCentral |
| Manual Xrefs | Databases |
|---|---|
| D00365 | KEGG DRUG |
| LSM-4970 | LINCS |
| 1606 | DrugCentral |
| HMDB0014332 | HMDB |
| Registry Numbers | Sources |
|---|---|
| CAS:846-49-1 | KEGG COMPOUND |
| CAS:846-49-1 | DrugCentral |